FDA market entry & submissions
Pathway strategy (510(k), De Novo, PMA), classification, Q-Sub, submission preparation and responses to FDA additional information requests.
Services
Engage us for a single submission or a full market-access program, always under a written scope.
Pathway strategy (510(k), De Novo, PMA), classification, Q-Sub, submission preparation and responses to FDA additional information requests.
Technical documentation, General Safety and Performance Requirements (GSPR), clinical and performance evaluation, ISO 14971 risk management files and post-market surveillance plans. We work directly with notified bodies.
Market sequencing, dossiers and submissions across North America, Europe, the Middle East and Asia, coordinated with your distributors. Country coverage is confirmed during scoping.
FDA’s Quality Management System Regulation (QMSR, 21 CFR Part 820) took effect on 2 February 2026 and incorporates ISO 13485:2016 by reference. Our certified ISO 13485 internal auditors run QMSR gap assessments, update your procedures and prepare you for FDA inspections and notified body audits. Technical file review and team training.
Institutional Review Board (IRB) packages and study documents, and clinical pathway design.
Available on their own or alongside a project. Not every manufacturer needs them.
For manufacturers outside the US: FDA establishment registration and device listing, annual renewal, and US Agent service. Registration must be renewed every year.
FDA FY2027 annual registrationCalifornia notary public, apostille, and in-house translation of regulatory documents.
Compliance continues long after the first clearance. We support the full product lifecycle.
Why choose Reglo
Our team has filed across the categories below, from capital equipment and implants to wearable monitors, IVD and software.
CT, MRI, PET/CT, ophthalmic OCT, cerebral oximetry, wearable ECG, pulse oximeter and blood glucose monitoring devices
Surgical robots and navigation, microwave and cryoablation, dental and aesthetic lasers, IPL
Non-invasive ventilators, infusion and syringe pumps, blood warmers, neonatal incubators
Hip and knee replacement systems, gastric balloons and bands, sterile syringes, ablation needles, PRP kits, device disinfectant
NT-proBNP heart failure assay, lab-on-chip and exosome microfluidic diagnostics
Software as a Medical Device (SaMD), including medical image processing software
Yes. We align with your distributors on requirements, documents and timelines so everyone works from one plan.
Experienced regulatory affairs professionals. Translation is handled in-house; we coordinate test labs and work directly with notified bodies.
Tell us about your device and where you want to sell it. We will give you an honest view of the pathway and a first step.